CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 62.11 CNY -8.12% Market Closed
Market Cap: 7.1B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

Intrinsic Value

The intrinsic value of one CanSino Biologics Inc stock under the Base Case scenario is 67.83 CNY. Compared to the current market price of 62.11 CNY, CanSino Biologics Inc is Undervalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
67.83 CNY
Undervaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
CanSino Biologics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CanSino Biologics Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CanSino Biologics Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about CanSino Biologics Inc

Provide an overview of the primary business activities
of CanSino Biologics Inc.

What unique competitive advantages
does CanSino Biologics Inc hold over its rivals?

What risks and challenges
does CanSino Biologics Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CanSino Biologics Inc.

Provide P/S
for CanSino Biologics Inc.

Provide P/E
for CanSino Biologics Inc.

Provide P/OCF
for CanSino Biologics Inc.

Provide P/FCFE
for CanSino Biologics Inc.

Provide P/B
for CanSino Biologics Inc.

Provide EV/S
for CanSino Biologics Inc.

Provide EV/GP
for CanSino Biologics Inc.

Provide EV/EBITDA
for CanSino Biologics Inc.

Provide EV/EBIT
for CanSino Biologics Inc.

Provide EV/OCF
for CanSino Biologics Inc.

Provide EV/FCFF
for CanSino Biologics Inc.

Provide EV/IC
for CanSino Biologics Inc.

Show me price targets
for CanSino Biologics Inc made by professional analysts.

What are the Revenue projections
for CanSino Biologics Inc?

How accurate were the past Revenue estimates
for CanSino Biologics Inc?

What are the Net Income projections
for CanSino Biologics Inc?

How accurate were the past Net Income estimates
for CanSino Biologics Inc?

What are the EPS projections
for CanSino Biologics Inc?

How accurate were the past EPS estimates
for CanSino Biologics Inc?

What are the EBIT projections
for CanSino Biologics Inc?

How accurate were the past EBIT estimates
for CanSino Biologics Inc?

Compare the revenue forecasts
for CanSino Biologics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CanSino Biologics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CanSino Biologics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of CanSino Biologics Inc compared to its peers.

Compare the P/E ratios
of CanSino Biologics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing CanSino Biologics Inc with its peers.

Analyze the financial leverage
of CanSino Biologics Inc compared to its main competitors.

Show all profitability ratios
for CanSino Biologics Inc.

Provide ROE
for CanSino Biologics Inc.

Provide ROA
for CanSino Biologics Inc.

Provide ROIC
for CanSino Biologics Inc.

Provide ROCE
for CanSino Biologics Inc.

Provide Gross Margin
for CanSino Biologics Inc.

Provide Operating Margin
for CanSino Biologics Inc.

Provide Net Margin
for CanSino Biologics Inc.

Provide FCF Margin
for CanSino Biologics Inc.

Show all solvency ratios
for CanSino Biologics Inc.

Provide D/E Ratio
for CanSino Biologics Inc.

Provide D/A Ratio
for CanSino Biologics Inc.

Provide Interest Coverage Ratio
for CanSino Biologics Inc.

Provide Altman Z-Score Ratio
for CanSino Biologics Inc.

Provide Quick Ratio
for CanSino Biologics Inc.

Provide Current Ratio
for CanSino Biologics Inc.

Provide Cash Ratio
for CanSino Biologics Inc.

What is the historical Revenue growth
over the last 5 years for CanSino Biologics Inc?

What is the historical Net Income growth
over the last 5 years for CanSino Biologics Inc?

What is the current Free Cash Flow
of CanSino Biologics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for CanSino Biologics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CanSino Biologics Inc

Current Assets 4.5B
Cash & Short-Term Investments 3.5B
Receivables 588.2m
Other Current Assets 421.7m
Non-Current Assets 3.6B
Long-Term Investments 477.1m
PP&E 2.6B
Intangibles 242.7m
Other Non-Current Assets 259m
Current Liabilities 1.9B
Accounts Payable 77.8m
Accrued Liabilities 81m
Short-Term Debt 689.1m
Other Current Liabilities 1B
Non-Current Liabilities 1.2B
Long-Term Debt 1B
Other Non-Current Liabilities 187m
Efficiency

Earnings Waterfall
CanSino Biologics Inc

Revenue
748.5m CNY
Cost of Revenue
-241.7m CNY
Gross Profit
506.8m CNY
Operating Expenses
-1.2B CNY
Operating Income
-667.8m CNY
Other Expenses
-52.4m CNY
Net Income
-720.1m CNY

Free Cash Flow Analysis
CanSino Biologics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

CanSino Biologics Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 1-Year Revenue Growth
36/100
Profitability
Score

CanSino Biologics Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CanSino Biologics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Negative Net Debt
57/100
Solvency
Score

CanSino Biologics Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CanSino Biologics Inc

Wall Street analysts forecast CanSino Biologics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CanSino Biologics Inc is 62.57 CNY with a low forecast of 54.54 CNY and a high forecast of 72.11 CNY.

Lowest
Price Target
54.54 CNY
12% Downside
Average
Price Target
62.57 CNY
1% Upside
Highest
Price Target
72.11 CNY
16% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CanSino Biologics Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CanSino Biologics Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos

Profile

CanSino Biologics Inc Logo
CanSino Biologics Inc

Country

China

Industry

Pharmaceuticals

Market Cap

7.1B CNY

Dividend Yield

0%

Description

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Contact

TIANJIN
Tianjin
West District Biomedical Park, No. 185 South Avenue, West District, Economic and Technological Development Zone
+862258213766.0
www.cansinotech.com

IPO

2019-03-28

Employees

1 946

Officers

Co-Founder, Executive Chairman, CEO & GM
Dr. Xuefeng Yu Ph.D.
Co-Founder, Deputy GM & Chief Scientific Officer
Dr. Tao Zhu Ph.D.
Co-Founder, Executive VP & Deputy GM
Dr. Dongxu Qiu MBA, Ph.D.
COO, Deputy GM & Executive Director
Dr. Shou-Bai Chao Ph.D.
Chief Commercial Officer, Deputy GM & Executive Director
Ms. Jing Wang
Senior Director of New Technology Department
Mr. Chunlin Xin
Show More
Vice President of Marketing
Mr. Yonghui Wu
Board Secretary
Mr. Jin Cui
Joint Company Secretary
Mr. Ming King Chiu FCIS, FCS
Show Less

See Also

Discover More
What is the Intrinsic Value of one CanSino Biologics Inc stock?

The intrinsic value of one CanSino Biologics Inc stock under the Base Case scenario is 67.83 CNY.

Is CanSino Biologics Inc stock undervalued or overvalued?

Compared to the current market price of 62.11 CNY, CanSino Biologics Inc is Undervalued by 8%.

Back to Top